BPC-157 Research Peptide is a stable gastric pentadecapeptide studied through gastric mucosal models, nitric oxide signalling, angiogenesis markers, fibroblast activity and connective tissue repair endpoints
Some human antibiotics are also used in dogs, but dose, interval, duration, and whether the drug even fits the infection still require a veterinarian
Indicated Cases This formulation is most appropriate for: Adult cats 2.55 kg with FIP presenting alongside anaemia (confirmed by haematology or suspected clinically) Wet FIP cases with concurrent lethargy and appetite suppression disproportionate to effusion severity Dry FIP cases with systemic involvement and immune compromise Cases where owner or veterinarian wishes to consolidate daily antiviral injection with B12 supplementation Cats on concurrent medications that may affect appetite or GI absorption This Formulation Is Not the First Choice For Cats requiring therapeutic-dose B12 at intervals other than once daily maintain a separate B12 protocol as directed by your veterinarian Cats outside the 2.55 kg weight range select the appropriate concentration for your cat's weight Cats with no secondary systemic complications the standard 30mg/ml formulation is sufficient Concentration Selection Guide Administration Administer subcutaneously once daily
Recognizing these symptoms early allows for faster treatment and better outcomes
Verify labeling: peptide sequence, salt form, and reconstitution instructions
Individual Variability Risk: Responses to Dihexa can differ widely, influenced by genetics, lifestyle, and other health factors
